MORBELLI, SILVIA DANIELA
 Distribuzione geografica
Continente #
EU - Europa 21.062
Totale 21.062
Nazione #
IT - Italia 21.062
Totale 21.062
Città #
Genova 15.538
Rapallo 3.211
Genoa 2.215
Bordighera 98
Totale 21.062
Nome #
1,25-Dihydroxy vitamin D and coronary microvascular function 281
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 159
18F-NaF uptake by atherosclerotic plaque on PET/CT imaging: Inverse correlation between calcification density and mineral metabolic activity 153
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 148
18F-FDG PET/CT is a prognostic biomarker in patients affected by bone metastases from breast cancer in comparison with 18F-NaF PET/CT. 144
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 140
Amyloid positron emission tomography and cognitive reserve. 140
Diagnostic utility of FDG-PET in the differential diagnosis between different forms of primary progressive aphasia 139
Alzheimer’s disease markers from structural MRI and FDG-PET brain images 138
Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study 136
Intrabone Transplant of Cord Blood Stem Cells Establishes a Local Engraftment Store: A Functional PET/FDG Study 135
Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers 133
Baseline and ongoing PET-derived factors predict detrimental effect or potential utility of 18F-FDG PET/CT (FDG-PET/CT) performed for surveillance in asymptomatic lymphoma patients in first remission. 130
A Positron Emission Tomography/Computed Tomography (PET/CT) Evaluation of Asymptomatic Abdominal Aortic Aneurysms: Another Point of View. 128
Correlation between thoracic aorta 18F-natrium fluoride uptake and cardiovascular risk 128
Witnessing ischemia or proofing coronary atherosclerosis: two different windows on the same or on different pathways precipitating cardiovascular events? 127
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 126
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 126
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 125
Tissue specificity in fasting glucose utilization in slightly obese diabetic patients submitted to bariatric surgery. 125
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 123
Direct relationship between cell density and FDG uptake in asymptomatic aortic aneurysm close to surgical threshold: an in vivo and in vitro study. 123
Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study 123
Neuroimaging findings in mild cognitive impairment 123
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes 121
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 121
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 118
Reduced coronary flow reserve in patients with primary hyperparathyroidism: a study by G-SPECT myocardial perfusion imaging. 117
Adult Advanced Chronic Lymphocytic Leukemia: Computational Analysis of Whole-Body CT Documents a Bone Structure Alteration 117
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. 116
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 116
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 116
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 115
Polymyalgia rheumatica or lymphoma recurrence? Positron emission tomography/computed tomography is a specific imaging technique that helps differential diagnosis 113
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 113
Nigro-caudate dopaminergic deafferentation: A marker of REM sleep behavior disorder? 113
What predicts cognitive decline in de novo Parkinson's disease? 113
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 113
Assessment of skeletal tumor load in metastasized castration-resistant prostate cancer patients: A review of available methods and an overview on future perspectives 113
An H-TERT Mutated Skin Metastasis as First Occurrence in a Case of Follicular Thyroid Carcinoma 113
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 112
Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. 112
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 111
Brain perfusion SPECT provides new insight on neurobiological effects of hyperbaric hyperoxia. 111
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 109
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 109
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 109
Interspinous bursitis is common in polymyalgia rheumatica, but is not associated with spinal pain 109
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 107
Relationship between circulating anti-thyroglobulin antibodies (TgAb) and tumor metabolism in patients with differentiated thyroid cancer (DTC): prognostic implications 107
Striatal dopamine transporter SPECT quantification: head-to-head comparison between two three-dimensional automatic tools 107
The role of the serotonergic system in REM sleep behavior disorder 106
Mapping brain morphological and functional conversion patterns in predementia late-onset bvFTD 106
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. 105
Doxorubicin effect on myocardial metabolism as a prerequisite for subsequent development of cardiac toxicity: A translational18F-FDG PET/CT observation 105
Case report: lenvatinib in neoadjuvant setting in a patient affected by invasive poorly differentiated thyroid carcinoma 105
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. 104
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 104
A new frontier for amyloid PET imaging: multiple sclerosis 103
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 102
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment 102
Validation of an optimized SPM procedure for FDG-PET in dementia diagnosis in a clinical setting 101
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease 101
Early identification of MCI converting to AD: a FDG PET study 100
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study 100
Trafficking and homing of systemically administered stem cells: the need for appropriate analysis tools of radionuclide images 99
Divergent determinants of 18F-NaF uptake and visible calcium deposition in large arteries: relationship with Framingham risk score. 99
New tracers and new perspectives for molecular imaging in Lewy body diseases 99
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 98
G6Pase location in the endoplasmic reticulum: Implications on compartmental analysis of FDG uptake in cancer cells 97
Obligatory role of endoplasmic reticulum in brain FDG uptake 97
Efficacy of sorafenib and impact on cardiac function in patients with thyroid cancer: a retrospective analysis. 96
Brain glucose metabolism and cognitive function in patients with amnestic Mild Cognitive Impairment (MCI) 96
Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. 96
Bilateral motor and premotor cortex hypometabolism in a case of Mills syndrome 96
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study 96
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. 95
Increased myocardial 18 F-FDG uptake as a marker of Doxorubicin-induced oxidative stress 95
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 95
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 94
Comparisons between glucose analogue 2-deoxy-2-((18)F)fluoro-D-glucose and (18)F-sodium fluoride positron emission tomography/computed tomography in breast cancer patients with bone lesions 94
Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution 94
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 94
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study 93
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage. 92
Differentiated thyroid cancer incidentally detected by 18F-FDG PET/CT: Patient's future in a hot-spot? 92
Presynaptic dopaminergic neuroimaging in REM sleep behavior disorder: A systematic review and meta-analysis 92
Standardized Uptake Value Ratio-Independent Evaluation of Brain Amyloidosis 92
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 91
Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. 91
Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging 91
Functional imaging in pre-motor Parkinson's disease 90
The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [123I]FP-CIT SPECT imaging 90
Comparative diagnostic accuracy of 18F-FDG PET/CT for breast cancer recurrence 90
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: Results from the ENC-DAT database 89
All-trans retinoic acid skews monocyte differentiation into interleukin-12-secreting dendritic-like cells 89
Progressive disgregation of brain networking from normal aging to Alzhimer's Disease. Independent Component Analysis on FDG-PET data 89
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 88
High frequency of capsular knee involvement in polymyalgia rheumatica/giant cell arteritis patients studied by positron emission tomography 87
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 87
Totale 11.111
Categoria #
all - tutte 69.918
article - articoli 62.182
book - libri 0
conference - conferenze 6.157
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.579
Totale 139.836


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.053 0 0 0 0 0 0 0 0 0 205 458 390
2019/20206.003 279 160 188 381 488 649 818 475 665 1.059 669 172
2020/20212.403 139 209 178 221 141 251 200 222 193 263 184 202
2021/20223.300 82 114 231 381 151 278 136 679 265 355 143 485
2022/20233.748 303 331 63 377 549 564 35 334 598 89 459 46
2023/20241.878 118 262 46 321 196 471 162 166 109 27 0 0
Totale 21.766